Filtering by:
TreatmentFDA Approves Lutathera for Certain Digestive Tract Cancers
The US Food and Drug Administration (FDA) has approved Lutathera (lutetium Lu 177 dotatate) to treat people with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Top 10 Cancer News Stories of 2017
In 2017 we published stories about new findings in cancer risk factors, prevention, treatment, and survivorship issues. Our writers and editors have chosen the 10 most significant stories that made headlines on cancer.org this year.
New Cancer Drug Approvals From 2017
In 2017, the FDA approved several new drug treatments for different cancer types that American Cancer Society editors believe will make a significant difference.
Study Shows US Cancer Drug Costs Increasing Despite Competition
A study published in Journal of Clinical Oncology shows that once cancer drugs go on the market, their prices tend to increase over time, sometimes sharply, even in the face of competition.